Search - tctmd.com

Displaying 21 - 40 of 49

Sort: Relevancy | Date

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

Presentation TCT 2017

Underutilization of TAVR in Minority Populations: Scope, Etiologies, and Possible Solutions

Presenter: Eberhard Grube, James B. Hermiller Jr., Oluseun Alli

November 01, 2017

News Industry News

Five-Year Data from the Medtronic ENGAGE Registry Demonstrate Durable, Consistent, and Proven Outcomes in Real-World Setting

April 26, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

News Daily News

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Michael H. Wilson

July 12, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

Presentation TVT 2016

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

Presenter: Adam B. Greenbaum

June 17, 2016

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Industry News

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

June 08, 2015

News Daily News

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

L.A. McKeown

December 21, 2014

Presentation TCT 2014

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

Advertisement

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Underutilization of TAVR in Minority Populations: Scope, Etiologies, and Possible Solutions

Five-Year Data from the Medtronic ENGAGE Registry Demonstrate Durable, Consistent, and Proven Outcomes in Real-World Setting

REVA to Expand FANTOM II Trial to More Complex Cases

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content